Primary Record
Strictosamide
Note: Only for scientific research or as raw materials for production.
- In stock
- 3,676 g
- Purity
- 98.4 %
- CAS
- 23141-25-5
Compound Identifiers & Properties
- CAS
- 23141-25-5
- PubChem CID
- 10345799
- SMILES
- C=C[C@@H]1[C@@H]2C[C@H]3C4=C(CCN3C(=O)C2=CO[C@H]1O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C6=CC=CC=C6N4
- Canonical SMILES
- C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C2C(=O)N3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]21
Names & Synonyms
- Strictosamide
- Strictosidine lactam
- 23141-25-5
- RefChem:186022
- CHEMBL4438424
- DTXSID60438421
- C26H30N2O8
- orb1297201
- SCHEMBL7906980
- CHEBI:80684
- DTXCID20389243
- 2-(1H-pyrrol-1-ylmethyl)pyridine
- HY-N1198
- BDBM50531272
- NP0312
- ZINC28541549
- AKOS032948641
- EBC-616584
- CID10345799
- 4CN-1941
- DA-78062
- MS-29249
- XS163684
- J412.421I
- CS-0016490
- FT-0701015
- W1090
- C16724
- E80799
- A971943
- Q27149725
- (1S,18S,19R,20S)-19-ethenyl-18-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15-pentaen-14-one
- 5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one, 1-ethenyl-2-(beta-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-, (1R,2S,13bS,14aS)-
- 3-epi-Vincosamide; Isovincoside lactam; Strictosidine lactam
- 1,2,7,8,13,13BBETA,14,14AALPHA-OCTAHYDRO-1BETA-VINYL-2ALPHA-(BETA-D-GLUCOPYRANOSYLOXY)-5H-INDOLO[2,3-A]PYRANO[3,4-G]QUINOLIZINE-5-ONE
- (15beta)-16alpha-Vinyl-17beta-(beta-D-glucopyranosyloxy)-19,20-didehydro-18-oxayohimban-21-one
- (15beta)-19,20-Didehydro-16alpha-ethenyl-17beta-(beta-D-glucopyranosyloxy)-18-oxayohimban-21-one
- (1R)-1beta-Ethenyl-2alpha-(beta-D-glucopyranosyloxy)-1,2,7,8,13,13bbeta,14,14aalpha-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one
- (1R,2S,13bS,14aS)-1-Ethenyl-2-(|_-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one
- (1S,18S,19R,20S)-18-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-19-vinyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15-pentaen-14-one
- (1S,18S,19R,20S)-19-ethenyl-18-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,10.04,9.015,20)henicosa-2(10),4,6,8,15-pentaen-14-one
- (1S,18S,19R,20S)-19-ethenyl-18-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7,15-pentaen-14-one
- (1S,18S,19R,20S)-19-ethenyl-18-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15-pentaen-14-one
- 16alpha-Ethenyl-21-oxo-15beta-19,20-didehydro-18-oxayohimban-17beta-yl beta-D-glucopyranoside
- 2-(acetoxymethyl)-6-((5-oxo-1-vinyl-1,2,7,8,13,13b,14,14a-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizin-2-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate
- 5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one, 1-ethenyl-2-(|A-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-, (1R,2S,13bS,14aS)-
- 5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one,1-ethenyl-2-(b-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-,(1R,2S,13bS,14aS)-